The civic record
Read. Follow. Verify.Medicare Common Ownership Transparency Act of 2023
Record date · December 17, 2024
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
This bill requires Medicare Advantage plans and prescription drug plans to disclose ownership information for their affiliated health care providers and pharmacies. It also mandates that the Medicare Payment Advisory Commission (MedPAC) produce regular reports analyzing how this corporate ownership affects health care access, pricing, and patient outcomes.
The bill aims to increase transparency regarding ''—where insurance plans, pharmacy benefit managers, and health care providers are owned by the same parent company—which may influence the costs and quality of care for millions of Medicare beneficiaries.
- Mr. Murphy is a member of the U.S. House of Representatives. context
- The Medicare Payment Advisory Commission (MedPAC) is an independent congressional agency that advises the U.S. Congress on issues affecting the Medicare program. context
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Medicare Advantage organizations
Must submit new ownership and financial data to the Secretary of Health and Human Services every three years.
Prescription drug plan sponsors
Must disclose ownership information for affiliated pharmacies and pharmacy benefit managers.
Medicare Payment Advisory Commission
Required to conduct new, periodic research and report findings to Congress.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What is 'vertical integration' in this context?
How often will these reports be required?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently filed. The next step in the legislative lifecycle is Committee.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Focus on Vertical Integration
The bill signals a legislative shift toward investigating the financial relationships between insurers, PBMs, and providers, rather than just focusing on drug prices alone.
Connected Entities
Sources
www.congress.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz25Current news / social attention level
Publisher tools